Recon: AstraZeneca announces $15B China investment; UK says severe pancreatitis and death linked to GLP-1 drugs
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States